Toggle Main Menu Toggle Search

Open Access padlockePrints

Osteoprotegerin increases parallel to insulin resistance in obese adolescents

Lookup NU author(s): Dr Chris Kotanidis


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2018, © 2018 Taylor & Francis. Purpose/Aim of the Study: Osteoprotegerin (OPG) is an α tumor necrosis factor receptor superfamily glucoprotein that acts as a decoy receptor for the receptor activator of nuclear factor kappa B ligand (RANKL), exerting an antiresoptive bone effect. It was recently shown that OPG/RANKL axis is activated during vascular calcification, contributing to atherosclerotic lesions formation. Additionally, OPG levels are characterized as an independent risk factor for overall vascular mortality in obese adults. We aimed to investigate OPG levels in children/adolescents with obesity and explore possible relations with obesity-related insulin resistance (IR). Material and Methods: A total of 160 participants (85 obese) were enrolled. Participants with obesity underwent an oral glucose tolerance test. IR was evaluated according to the homeostasis model assessment-insulin resistance index. Serum OPG levels were determined. Results: OPG levels did not differ significantly between obese subjects and controls in the total sample (p = 0.133). However, in the adolescents’ subgroup, serum OPG levels were significantly increased in obesity (p = 0.019). After stratifying participants according to their IR status, only subjects with both obesity and IR exhibited increased OPG levels compared to controls (p < 0.001). Factor analysis further associated OPG levels variation to insulin levels variation and to IR. Conclusions: Obese individuals demonstrate increased serum OPG levels during puberty. Obesity per se is not the potent factor for this increase; indeed, IR accompanying obesity seems to exert a fundamental role in OPG upregulation.

Publication metadata

Author(s): Kotanidou EP, Kotanidis CP, Giza S, Serbis A, Tsinopoulou V-R, Karalazou P, Tzimagiorgis G, Galli-Tsinopoulou A

Publication type: Article

Publication status: Published

Journal: Endocrine Research

Year: 2019

Volume: 44

Issue: 1-2

Pages: 9-15

Online publication date: 07/06/2018

Acceptance date: 16/05/2018

ISSN (print): 0743-5800

ISSN (electronic): 1532-4206

Publisher: Taylor and Francis Ltd


DOI: 10.1080/07435800.2018.1480630

PubMed id: 29877745


Altmetrics provided by Altmetric